Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer | Zendy

Gang Chen | Zendy; Xiangyan Liu | Zendy; Zhou Wang | Zendy; Fanying Liu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer

Author(s) -

Gang Chen,

Xiangyan Liu,

Zhou Wang,

Fanying Liu

Publication year - 2009

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2009.08.005

Subject(s) - lung cancer , medicine , vascular endothelial growth factor , immunohistochemistry , cancer , lung , proportional hazards model , pathology , metastasis , oncology , vascular endothelial growth factor c , carcinoma , hazard ratio , gastroenterology , vascular endothelial growth factor a , vegf receptors , confidence interval

Mediastinal lymph node metastasis (N2) is a key prognostic factor for lung carcinoma. This study was undertaken to investigate the relationship between vascular endothelial growth factor C (VEGF-C) expression and postoperative early recurrence in patients with N2 non-small-cell lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research